Who has invested in Callio Therapeutics?

Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus are named among the investors backing Callio Therapeutics.

Callio Therapeutics Funding: $187M Raised, Series A (2025)

Callio Therapeutics funding overview

Callio Therapeutics is a Biotech company based in Seattle. Callio Therapeutics has raised $187M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Callio Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus and 4 others. 10 distinct backers are named across the disclosed rounds.

Callio Therapeutics at a glance

Total raised: $187M
Latest round: Series A
Latest round date: March 2025
Industry: Biotech
Headquarters: Seattle
Notable investors: Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus, Norwest, Pureos Bioventures

Frequently asked about Callio Therapeutics funding

How much has Callio Therapeutics raised?: Callio Therapeutics has raised $187M in total disclosed funding across the rounds on record.
Who has invested in Callio Therapeutics?: Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus are named among the investors backing Callio Therapeutics.
What was the latest Callio Therapeutics funding round?: The most recent disclosed round is a Series A, announced in March 2025.
Where is Callio Therapeutics based?: Callio Therapeutics is based in Seattle.
What sector does Callio Therapeutics operate in?: Callio Therapeutics is tracked under Biotech from Seattle, with $187M in disclosed funding.
When did Callio Therapeutics last raise?: The last disclosed Callio Therapeutics round closed in March 2025 at Series A.

Totals shown for Callio Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Seattle and the investors behind them below.

Callio Therapeutics Funding: $187M Raised, Series A (2025)

Callio Therapeutics funding overview

Callio Therapeutics at a glance

Frequently asked about Callio Therapeutics funding

Callio Therapeutics founders (1)

Companies related to Callio Therapeutics (40)

Browse related funding lists (9)